Maravai LifeSciences Holdings, Inc.
MRVI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,431 | $1,645 | $3,584 | $9,156 |
| - Cash | $322 | $575 | $632 | $551 |
| + Debt | $377 | $611 | $585 | $575 |
| Enterprise Value | $1,485 | $1,681 | $3,537 | $9,180 |
| Revenue | $259 | $289 | $883 | $799 |
| % Growth | -10.3% | -67.3% | 10.5% | – |
| Gross Profit | $108 | $140 | $714 | $659 |
| % Margin | 41.8% | 48.5% | 80.9% | 82.4% |
| EBITDA | -$157 | $712 | $610 | $586 |
| % Margin | -60.5% | 246.6% | 69.1% | 73.3% |
| Net Income | -$145 | -$119 | $220 | $182 |
| % Margin | -55.9% | -41.2% | 24.9% | 22.8% |
| EPS Diluted | -1.05 | -0.9 | 1.67 | 1.56 |
| % Growth | -16.7% | -153.9% | 7.1% | – |
| Operating Cash Flow | $7 | $126 | $536 | $369 |
| Capital Expenditures | -$30 | -$66 | -$17 | -$15 |
| Free Cash Flow | -$22 | $61 | $519 | $354 |